4//SEC Filing
Nixon Ronald T 4
Accession 0000897423-20-000051
CIK 0000714256other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 10:31 AM ET
Size
7.3 KB
Accession
0000897423-20-000051
Insider Transaction Report
Form 4
Nixon Ronald T
DirectorChief Executive Officer10% Owner
Transactions
- Award
Common Stock
2020-02-24+7,229→ 7,229 total
Holdings
- 2,452,731(indirect: See Footnote)
Common Stock
- 963,856(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Reflects shares of Common Stock owned of record by CGI Cellerate RX, LLC, which is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Nixon is a manager of Catalyst Rochal, LLC. By virtue of these relationships, Mr. Nixon, Catalyst Rochal, LLC and CGI Cellerate RX, LLC may be deemed to share voting and dispositive control over the Common Stock. Mr. Nixon and Catalyst Rochal, LLC disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein.
- [F2]Reflects shares of Common Stock owned of record by FA Sanara, LLC ("FA Sanara"). FA Sanara is managed by Family Alignment, LLC ("Family"), which is managed by Catalyst Group, Inc.("Catalyst"). Mr. Nixon is controlling shareholder and President of Catalyst. Mr. Nixon, Catalyst, Family and FA Sanara may be deemed to share voting and dispositive control over the Common Stock. Mr. Nixon, Catalyst and Family disclaim beneficial ownership of any Common Stock held or beneficially owned by FA Sanara, except to the extent of each of their pecuniary interests therein.
Documents
Issuer
Sanara MedTech Inc.
CIK 0000714256
Entity typeother
Related Parties
1- filerCIK 0001322573
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 10:31 AM ET
- Size
- 7.3 KB